Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05139498 · ClinicalTrials.gov registry record · NA
Conservative Management for PAS Pilot
A NA study of Placenta Accreta, sponsored by University of Utah.
- Recruiting
- Registry status
- NA
- Development phase
- 32
- Enrollment target
- 1
- Study location
NCT05139498 is a NA study of Placenta Accreta that is actively recruiting participants, run by University of Utah. The registered enrollment target is 32 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05139498, a NA study of Placenta Accreta, is actively recruiting participants, sponsored by University of Utah.
- RECRUITING
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
Conservative in situ management is a promising alternative treatment to hysterectomy for patients with placenta accreta spectrum and may be safer and preferable for some patients. This study will assess feasibility of a future randomized clinical trial comparing these treatments and provide novel data to inform shared decision-making and cost-effective care for patients with this deadly pregnancy disorder.
Conditions Studied
Interventions
- PROCEDURE Conservative management for placenta accreta spectrum (PAS)
- PROCEDURE Cesarean hysterectomy for placenta accreta spectrum (PAS)
Study Locations (1)
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2022-05-26 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05139498
The ClinicalTrials.gov registry entry for NCT05139498 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Placenta Accreta appearing as the primary indexed condition, and to 2 interventions - of which Conservative management for placenta accreta spectrum (PAS) is the first listed.
NCT05139498 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.
Frequently Asked Questions
What is clinical trial NCT05139498 about?
NCT05139498 is a clinical study titled "Conservative Management for PAS Pilot". Conservative in situ management is a promising alternative treatment to hysterectomy for patients with placenta accreta spectrum and may be safer and preferable for some patients. This study will assess feasibility of a future randomized clinical trial comparing these treatments and provide novel da...
What is the current status of trial NCT05139498?
This trial is currently recruiting. It is a NA study. The enrollment target is 32 participants. The study started on 2022-05-26. Estimated completion is 2026-06-30.
What conditions does trial NCT05139498 study?
This clinical trial studies the following conditions: Placenta Accreta.
What interventions are being tested in trial NCT05139498?
The interventions under investigation include: Conservative management for placenta accreta spectrum (PAS) (PROCEDURE), Cesarean hysterectomy for placenta accreta spectrum (PAS) (PROCEDURE).
Who is sponsoring clinical trial NCT05139498?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05139498 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Placenta Accreta
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.